000 01261 a2200361 4500
005 20250518013514.0
008 ####s 0 0 eng d
022 _a2352-3018
024 7 _a10.1016/S2352-3018(18)30296-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEron, Joseph J
245 0 0 _aSafety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trial.
_h[electronic resource]
260 _bThe lancet. HIV
_cDec 2018
500 _aPublication Type: Journal Article
700 1 _aLelievre, Jean-Daniel
700 1 _aKalayjian, Robert
700 1 _aSlim, Jihad
700 1 _aWurapa, Anson K
700 1 _aStephens, Jeffrey L
700 1 _aMcDonald, Cheryl
700 1 _aCua, Eric
700 1 _aWilkin, Aimee
700 1 _aSchmied, Brigitte
700 1 _aMcKellar, Mehri
700 1 _aCox, Stephanie
700 1 _aMajeed, Sophia R
700 1 _aJiang, Shuping
700 1 _aCheng, Andrew
700 1 _aDas, Moupali
700 1 _aSenGupta, Devi
773 0 _tThe lancet. HIV
856 4 0 _uhttps://doi.org/10.1016/S2352-3018(18)30296-0
_zAvailable from publisher's website
999 _c29167918
_d29167918